.webp)
.webp)
.webp)
.webp){kind=icon}
.webp)
.webp){kind=icon}
.webp)
.webp)
.webp)
.webp)
Dr Menekse Tekin
Owner, Naturel Dent
It is tracking lab, material, and treatment-level costs so profitability is visible before pricing and billing.
Because hidden costs and inconsistent pricing silently reduce profit across completed treatments.
At minimum: lab fees, key material usage, external service costs, and agreed time-based cost logic.
Yes. When costing is embedded in workflow, spreadsheet dependency drops significantly.
With real-time case-level visibility, teams can see expected margin during planning.
Yes. Quotes become evidence-based and less vulnerable to underpricing.
Clear and structured pricing improves transparency during patient discussions.
Yes. Agreed deduction rules can be applied consistently across cases.
Not when integrated with charting and planning in the same clinical flow.
Yes. Shared structured data reduces mismatch between plan and payment conversation.
Variance can be flagged so assumptions are corrected before margin erosion expands.
Yes. Cleaner pricing logic and fewer surprises improve decision confidence.
Case margin %, lab-cost ratio, discount impact, rework cost, and quote-to-start conversion.
Yes. This is essential for leakage detection and pricing accuracy.
Absolutely. Shared cost logic enables cleaner site-to-site comparisons.
It converts stock movement into treatment-level cost evidence.
Yes. Margin reporting supports supplier, staffing, and pricing strategy decisions.
No. Single-site clinics also benefit because small leakage compounds quickly.
.webp)
.webp)
.svg)
